MLTX · MoonLake Immunotherapeutics · Proposed Sales
Market Cap
$829.79M
Shares
85.11M
Volume · Oct 20
1.24M
Avg daily vol (3M)
1.51M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-07-15 | Reich Kristian | Officer | 150,000 | 2026-07-15 | UBS Financial Services, Inc. |
| 2026-06-30 | Santos da Silva Jorge | Officer, CEO | 150,000 | 2026-06-30 | UBS Financial Services, Inc. |
| 2026-06-15 | Reich Kristian | Officer | 150,000 | 2026-06-15 | UBS Financial Services, Inc. |
| 2026-04-10 | Jorge Pedro Santos Radeck D Silva | CEO | 150,000 | 2026-04-10 | UBS Financial Services Inc |
| 2026-04-09 | Bodenstedt Matthias | Officer, CFO | 160,870 | 2026-04-09 | UBS Financial Services, Inc. |
| 2026-03-31 | BVF PARTNERS L P/IL | 10% Stockholder, Affiliate of Director | 3,750,000 | 2026-03-31 | Goldman Sachs & Co. LLC |
| 2025-12-08 | Jorge Pedro Santos Radeck Da Silva | Officer, Director, CEO | 200,000 | 2025-12-08 | UBS Financial Services Inc |
| 2025-12-08 | Kristian Dieter Johannes Reich | Officer, Director, Chief Scientific Officer | 202,908 | 2025-12-08 | UBS Financial Services Inc |
| 2025-07-03 | Moukheibir Catherine | Director | 23,500 | 2025-07-03 | Fidelity Brokerage Services LLC |
| 2024-02-15 | Santos da Silva Jorge | CEO | 200,000 | 2024-02-15 | UBS Financial Services Inc |
| 2024-02-14 | Reich Kristian | Officer, CSO | 200,000 | 2024-02-14 | UBS Financial Services, Inc |
| 2023-12-20 | Bodenstedt Matthias | Officer, CFO | 5,264 | 2023-12-20 | UBS Financial Services, Inc. |
| 2023-12-19 | Bodenstedt Matthias | Officer, CFO | 94,736 | 2023-12-19 | UBS Financial Services, Inc. |
Showing 1–13 of 13 filings
Key facts
CIK
1821586
CUSIP
61559X104
13F (30d)
11 filings
11 filers
Visit website
Investor relations